28435 Sex steroids percutaneous penetration in vivo in man: Relationship to mathematical predictive model

2021 ◽  
Vol 85 (3) ◽  
pp. AB188
Author(s):  
Anuk Burli ◽  
Rebecca M. Law ◽  
Howard I. Maibach
2020 ◽  
Vol 112 ◽  
pp. 104614
Author(s):  
Anuk Burli ◽  
Rebecca M. Law ◽  
Jocelyn Rodriguez ◽  
Howard I. Maibach

1983 ◽  
Vol 81 (5) ◽  
pp. 388-392 ◽  
Author(s):  
Jerry L. McCullough ◽  
Gerald D. Weinstein ◽  
Michael G. Rosenblum ◽  
Jennifer J. Jenkins

2017 ◽  
Vol 1 ◽  
pp. 239784731772319 ◽  
Author(s):  
A Lymberopoulos ◽  
C Demopoulou ◽  
M Kyriazi ◽  
MS Katsarou ◽  
N Demertzis ◽  
...  

Objectives: Liposomes are reported as penetration enhancers for dermal and transdermal delivery. However, little is known about their percutaneous penetration and as to at which level they deliver encapsulated drugs. The penetration of multilamellar vesicles (MLVs) and small unilamellar vesicles (SUVs), in comparison to one of their lipid components, was investigated. Methods: Using the fluorescent lipid, Lissamine Rhodamine B-PE (R), as a constituent, MLV and SUV liposomes were prepared, tested, and R, MLV, or SUV were applied in vivo on the back of hairless mice. Absorption of each was evaluated at the levels of stratum corneum, living skin, and blood by fluorometry. Results: Penetration of the lipid R in stratum corneum in the nonliposomal form exceeded that in the liposomal form and only R penetrates the living skin in a statistically significant manner. No statistical significant absorption into blood was observed with either form. Conclusions: Liposomes size did not play an important role in penetration to stratum corneum. The lipid constituent in the nonliposomal form penetrated at higher rates into stratum corneum and living skin. Even though these liposomes entered stratum corneum, they were not significantly absorbed into viable skin or blood.


2002 ◽  
Vol 282 (1) ◽  
pp. E215-E221 ◽  
Author(s):  
Lionel Verdier ◽  
Yves Boirie ◽  
Sebastien Van Drieesche ◽  
Michelle Mignon ◽  
Rene-Jean Begue ◽  
...  

Glutamine synthetase, a key enzyme in the production of glutamine, is known to be induced by glucocorticoids and preserved in skeletal muscle during aging, but the effect of other steroids, such as sex steroids (progesterone, estradiol), is unknown in vivo. The aim of this study was to determine whether progesterone or estradiol plays a role in the regulation of glutamine synthetase (GS) with aging. The effects of glucocorticoids and sex steroids on muscle GS activity and mRNA expression were measured in adult (6–8 mo; n = 7 in each group) and aged (26 mo; n= 10 in each group) female Wistar rats after adrenalectomy (ADX), ovariectomy (OV), or both (ADXOV) and were compared with those in sham-operated (Sham) control rats. In tibialis anterior muscle, ADX noticeably decreased both GS activity and expression irrespective of age (50–60%; P < 0.05), whereas OV had no effect at either age. Progesterone and estradiol replacement had no effect on the recovery of muscle GS response in either ADX or OV rats, regardless of age. In contrast, heart GS activity was decreased by ADX in aged animals only. These results suggest that the reproductive endocrine status of female rats does not affect muscle GS activity either in muscle or in heart, in young or aged animals, and that the heart GS response to steroids may be differently regulated in aged rats.


1986 ◽  
Vol 75 (10) ◽  
pp. 968-972 ◽  
Author(s):  
Richard H.A. Guy ◽  
Eva M. Carlström ◽  
Daniel A.W. Bucks ◽  
Robert S. Hinz ◽  
Howard I. Maibach

Author(s):  
Paolo Mannella ◽  
Tommaso Simoncini ◽  
Andrea Riccardo Genazzani

AbstractSex steroids are known to regulate brain function and their role is so important that several diseases are strictly correlated with the onset of menopause when estrogen-progesterone deficiency makes neural cells much more vulnerable to toxic stimuli. Although in the past years several scientists have focused their studies on in vitro and in vivo effects of sex steroids on the brain, we are still far from complete knowledge. Indeed, contrasting results from large clinical trials have made the entire issue much more complicated. Currently we know that protective effects exerted by sex steroids depend on several factors among which the dose, the health of the cells and the type of molecule being used. In this review, we present an overview of the direct and indirect effects of estrogen and progesterone on the brain with specific focus on the molecular mechanisms by which these molecules act on neural cells.


1998 ◽  
Vol 16 ◽  
pp. S201
Author(s):  
M. Fartasch ◽  
M. Sugar ◽  
E. Schnetz ◽  
T. Göen ◽  
M. Schmelz

Sign in / Sign up

Export Citation Format

Share Document